Daunomycin, an antitumor antibiotic, in the treatment of neoplastic disease. Clinical evaluation with special reference to childhood leukemia.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000740:Anemia / Q000188:drug therapy*; D002648:Child; D002675:Child, Preschool; D003630:Daunorubicin / Q000627:therapeutic use* / Q000633:toxicity; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D008223:Lymphoma / Q000188:drug therapy*; D008297:Male; D008545:Melanoma / Q000188:drug therapy*; D008875:Middle Aged; D009447:Neuroblastoma / Q000188:drug therapy*; D012208:Rhabdomyosarcoma / Q000188:drug therapy*; D012512:Sarcoma, Ewing / Q000188:drug therapy*; D009396:Wilms Tumor / Q000188:drug therapy*
D003630:Daunorubicin